TAK Plans to Revise FY2025 Financial Results Due to $X Loss from AMITIZA Antitrust Litigation Verdict
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · Now $15.19
+0.9% in 1d after detection
Post-detection moves
1h
+0.2%
1d
+0.9%
3d
-0.2%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS